CAMBRIDGE, Mass., Aug. 1, 2024 /PRNewswire/ — Myeloid Therapeutics, Inc. (“Myeloid”), a clinical-stage immunology company advancing RNA therapeutics to conquer cancer, announced today its participation in the Barclays Biotech: 1×1 Private Company Symposium on Wednesday, August 7, 2024.
This event is being held in a virtual format during which Company management will participate in one-on-one meetings with investors.
About Myeloid Therapeutics
Myeloid Therapeutics is a clinical stage immunology company, engineering cutting-edge RNA technology to program immune cells to combat cancer and other deadly diseases. Myeloid is headquartered in Cambridge, MA.
For additional information, please visit, https://www.myeloidtx.com/ and follow us on LinkedIn and X/Twitter. For collaborative interests, write to [email protected].
Investor Contact
Amy Conrad
Juniper Point
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/myeloid-therapeutics-to-participate-in-barclays-biotech-1×1-private-company-symposium-302212768.html
SOURCE Myeloid Therapeutics
Featured image: Megapixl © Kentoh